Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates. - Wikidata - wikimedia - TriplyDB

Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

http://www.wikidata.org/entity/Q34453823

about

Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cells Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections.Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.Molecular characterization of fluoroquinolone-resistant Moraxella catarrhalis variants generated in vitro by stepwise selection.Presumed endocarditis caused by BRO beta-lactamase-producing Moraxella lacunata in an infant with Fallot's tetrad.The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.Evaluation of restriction endonuclease analysis of BRO beta-lactamases in clinical and carrier isolates of Moraxella catarrhalis.

P2860

Q33492145-0C304571-CBF9-4ED5-9A04-B146A91B3AC4 Q34778118-28BE74E5-24F4-4F68-808C-C5011F9A5E2A Q35924353-1F8808BB-7311-4EAD-9717-19EA724E43BB Q36976255-7299B1B2-C038-47A5-8E68-ACEDEEF5F08E Q37123450-11AC8A2A-9E60-46EF-86C1-65497FD64922 Q40112522-4F0A36B5-27EC-4A00-88CC-F3FDB83FCC34 Q40172811-5CCF74E0-5AA1-4B22-9972-83DA74848CFF Q42727329-5AF7AF16-8A2F-400F-8B26-E8026214AFC7 Q44571590-C42FBB0D-8EFA-4F10-B8B0-F969E8D65BE0

P2860

Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

http://www.wikidata.org/entity/Q34453823

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Production of BRO beta-lactama ...... oraxella catarrhalis isolates.

@ast

Production of BRO beta-lactama ...... oraxella catarrhalis isolates.

@en

Production of BRO beta-lactama ...... oraxella catarrhalis isolates.

@nl

type

label

Production of BRO beta-lactama ...... oraxella catarrhalis isolates.

@ast

Production of BRO beta-lactama ...... oraxella catarrhalis isolates.

@en

Production of BRO beta-lactama ...... oraxella catarrhalis isolates.

@nl

prefLabel

Production of BRO beta-lactama ...... oraxella catarrhalis isolates.

@ast

Production of BRO beta-lactama ...... oraxella catarrhalis isolates.

@en

Production of BRO beta-lactama ...... oraxella catarrhalis isolates.

@nl

P1433

Q34453823-21342D57-A2A9-4AC5-AA3A-C7C9AA37B756

P1476

Q34453823-B86C299E-A729-4B6B-958C-7FB1247F57A2

P2093

Q34453823-362979DC-FCC2-410E-94D6-66BCEDDBECBE

Q34453823-36BFC882-4ABD-4D32-A790-2EADB06C3FAC

Q34453823-38DB2571-3A3B-4AE8-8215-CC7E42CEDA5D

Q34453823-53FC7721-BD29-44A5-97BA-86242F9115D6

Q34453823-5E9146FA-3DE8-42AB-9982-0A54A232C8C5

Q34453823-915DC81C-4A5D-4A77-9769-B976DCD6B00E

Q34453823-D6F16652-8532-496B-A182-6092ED2DAB64

Q34453823-D86BDE59-4949-4F4A-A296-0FF61523440D

Q34453823-F18D68DB-BB60-4DA2-B4F4-13BFCC0C7561

P2860

Q34453823-036DBBB0-17BC-45A1-A15B-1214D0CE6D3B

Q34453823-18D96FFD-078D-437D-B9C1-6A137EAC438E

Q34453823-1F4BE42E-2EA0-482C-A422-0F0C07D9737E

Q34453823-291E870D-5327-42FE-A14B-20A07111DD30

Q34453823-36FE2236-31BD-4670-A123-7582C0CBE328

Q34453823-3F5BC450-CF03-45EA-AAE9-36C6AE4CF952

Q34453823-45B58AF8-0C5D-44AD-8CA7-86B01104E90C

Q34453823-61617138-E70C-433E-9631-A033A47ACA95

Q34453823-643E89B5-F177-41B0-A80A-805339725514

Q34453823-66B5EFE0-4A78-4BBA-8471-AFAB9E7596EF

P304

Q34453823-86C6A03A-C0AE-4E28-AFD4-A35DF6780F7A

P31

Q34453823-98571361-6D0F-456B-9FFF-E976153FDC0A

P356

Q34453823-71DFB9B7-27FA-432B-83C7-BE698C1D4864

P407

Q34453823-F9160219-61F3-4C02-8927-9E0F069FC4F2

P433

Q34453823-9DC2C598-2597-46DD-9200-9BCB996E0AD1

P478

Q34453823-3EFF692B-43F6-459A-827D-2C7766A0BC3B

P577

Q34453823-0F5871C1-E799-4B8E-880C-14DF3939371F

P698

Q34453823-D6AA64B2-AEA1-45F1-8DFD-BEAE5FF9E311

P932

Q34453823-F7D3BFC5-8D2B-4349-9F89-598276D25B35

P356

JCM.40.4.1546-1548.2002

P1433

Journal of Clinical Microbiology

P1476

Production of BRO beta-lactama ...... oraxella catarrhalis isolates.

@en

P2093

Ad C Fluit

http://www.w3.org/2001/XMLSchema#string

Andreas Beeck

http://www.w3.org/2001/XMLSchema#string

Franz-Josef Schmitz

http://www.w3.org/2001/XMLSchema#string

Jan Verhoef

http://www.w3.org/2001/XMLSchema#string

Karl Köhrer

http://www.w3.org/2001/XMLSchema#string

Mechthild Boos

http://www.w3.org/2001/XMLSchema#string

Mirella Perdikouli

http://www.w3.org/2001/XMLSchema#string

Susanne Mayer

http://www.w3.org/2001/XMLSchema#string

Sybille Scheuring

http://www.w3.org/2001/XMLSchema#string

P2860

Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997)

Complement-resistant Moraxella catarrhalis forms a genetically distinct lineage within the species.

Genetic diversity among strains of Moraxella catarrhalis: analysis using multiple DNA probes and a single-locus PCR-restriction fragment length polymorphism method.

Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.

Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?

Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.

Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis

Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.

Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.

Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.

P304

1546-1548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.40.4.1546-1548.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11923393

http://www.w3.org/2001/XMLSchema#string

P932

140350

http://www.w3.org/2001/XMLSchema#string